We would love to hear your thoughts about our site and services, please take our survey here.
Err.... You can put a limit order in at whatever price you want? I could put a limit order in to buy at 1p does not mean its ever going to get filled!!! If your honestly telling me you were able to place a limit order for 500k shares and you put less than 3p in there and you ...... *(face palm emoji)
Thats some broker you have! Its 3.05 to buy one single share and 3.55p for 500k for the rest of us mortals :P If you mean that delayed 500k order printed? go and look at the time, its 100% a buy, coincidentally the short position on IG has started reducing.
DHub I have stopped replying because honestly I cannot and should not compete with Haywain who gives factual straight answers to disprove whatever gibberish. I Agree I should not reply but I 100% support Haywain replying as he is without a doubt the ONLY expert in this field active on this board. Stu has taken over posting the irrelevant unrelated links that 121 used to post (coincidence) with an attempt to throw mud and FUD and Haywain has the knowledge to quickly with authority explain why he is talking out of his arase.
I agree it should not be a fight or an argument or anything that drags the board into the sewer. HOWEVER If Stu (who must be getting paid overtime and smells of desperation) posts something which is misleading, false or irrelevant then personally I appreciate when Haywain explains why, we all learn a little. Its in the silence and voids where the trolls thrive :P
What are you on about? Prevail was diluting? Did you even read the RNS? They took 1% equity, sorry but are you just trying to change the subject from you and island girl posting at exactly the same time like 3 days in a row?
From Haywain:
Navigating the intersection of financial markets and the development of life-saving cancer therapies presents a profound ethical dilemma. At the heart of this issue is a choice between prioritizing financial gain or valuing human life. Personally I hold the conviction that the advancement of medical treatments- particularly those with the potential to save lives should be elevated above monetary interests. I would willingly donate my shares to see this having the best chance of success.
Conversely, I recognize that the perspective of profiting from the challenges faced by companies striving to develop cancer therapies can be seen as deeply controversial if not morally reprehensible. To actively undermine or bet against the success of these endeavors for personal financial gain could be viewed as indirectly contributing to the loss of lives. In my view this borders on the unethical (at best) at worst- and I know this is controversial but I will caveat this with the general statement that forgives all "IMO" it is tantamount to manslaughter (ie causing the unintentional death of others - who could have otherwise received a beneficial treatment).
I believe that scientific advancements especially those with the power to cure diseases and save lives should be shielded from the volatility and the speculative nature of financial markets through short selling etc. I personally think there should be a moral imperative to support and protect the development of vital medical treatments from actions that could hinder their success. In short I would champion the pursuit of humanity over the pursuit of wealth.
1, Are you sh@66ing island girl OR are you the same person as thats what? 3 or 4 times in a row now posting the same thing at almost EXACTLY the same moment..... Multi profile much?
2, Neither I nor anyone else said anything about funding being non-dilutive, pretty much ANY form of funding we see is going to be dilutive, be it JV, PIPE, strategic investment etc. The issue being we dont see any urgent need for Vlad to do some big destructive DISCOUNT placing. Prevail invested at 6p when SP was what? 1.6p or something? That was dilutive but welcome.
3, Sorry if you dont like your morals being questioned, but Haywains post is 100% on point, big or small, effective or not, when you make the decision to short Hemogenyx, IF that decision has negative impacts on the company you are directly causing delays in treatment of REAL PEOPLE, and in this scenario, they probably just die. So I will go ahead and repost his post because it IS worth reading and considering if your even remotely human.
You are so naive pumpkin. You really don't understand how shorting hurts a company. I give up on you. To this day you have never once said what you actually believe hemogenyx SHOULD be worth. Your happy to blame Vlad and Mint but the people who short are angels in your eyes.
Navigating the intersection of financial markets and the development of life-saving cancer therapies presents a profound ethical dilemma. At the heart of this issue is a choice between prioritizing financial gain or valuing human life. Personally I hold the conviction that the advancement of medical treatments- particularly those with the potential to save lives should be elevated above monetary interests. I would willingly donate my shares to see this having the best chance of success.
Conversely, I recognize that the perspective of profiting from the challenges faced by companies striving to develop cancer therapies can be seen as deeply controversial if not morally reprehensible. To actively undermine or bet against the success of these endeavors for personal financial gain could be viewed as indirectly contributing to the loss of lives. In my view this borders on the unethical (at best) at worst- and I know this is controversial but I will caveat this with the general statement that forgives all "IMO" it is tantamount to manslaughter (ie causing the unintentional death of others - who could have otherwise received a beneficial treatment).
I believe that scientific advancements especially those with the power to cure diseases and save lives should be shielded from the volatility and the speculative nature of financial markets through short selling etc. I personally think there should be a moral imperative to support and protect the development of vital medical treatments from actions that could hinder their success. In short I would champion the pursuit of humanity over the pursuit of wealth.
Well said HH, I have actually avoided posting thus far to let a post from Haywain stay on page 1 as much as possible because it is so well written, raw and put in words much better than I can how I feel about shorting. On that subject in particular which has had alot of focus recently in my opinion, shorting here is just wrong, its not betting that Hemogenyx will fail its purely betting that Hemogenyx will need to raise funds via a placing and hoping to make it more expensive for the company by shorting. Having said that, I believe they have made a mistake and short shares MUST be bough back and I see that as a huge opportunity as the sheer scale means the SP will be pushed higher whenever these positions are closed.
I agree 100% that focus has been completely shifted away from the science and what the company HAS achieved and what happens next and been totally hijacked by wall to wall coverage of shorting and funding which is just bonkers and helps nobody but those who want focus distracted from the good work. The reality is Hemogenyx today is Clinical and Vlad has options, I have made my opinion clear, I could be wrong but IMO next news is launch of clinical trials, they had hoped to launch in 2023 but delays.... The key there is that they said that in September, giving themselves only 3 months including having CH lifted etc so they clearly did not anticipate a long delay between lifting CH and launching the trial, a few weeks at most. So next week I anticipate an update on HEMO-CAR-T trials and I fully expect to come with it some sort of funding arrangement which will put everybody at ease.
Worth remembering also that we have recently had some fantastic news on CBR and as is clear from the past few weeks updates have started to flow as Vlad has been released from dedicating so much time to getting CAR-T clinical. That work is done, they will announce trials and the doctors and Prevail etc will take over. It is staggering and amazing that the SP is still here, Hemogenyx is an absolute outlier in this field right now, but markets correct and adjust. Good luck to all shareholders who are supporting an amazing company hoping to save lives in the very near future!
Final note, please take the time to read the post last night from Haywain, it was excellent!
Stu, I am categorically stating I believe you are wrong, but the fact remains even if in some parallel universe you were right that would mean you have dedicated hours upon hours to try and convince people to sell with the single goal of dropping the share price so any placing would be lower and the company could raise less money to spend on research and clinical trials. Have you any idea how empty your soul must be to get joy out of that?
I know your just guessing, and I'm confident your wrong, but seriously? None of that seems off or wrong to you?
Pumpkin ofcourse 20mil is not the cause of the entire drop! Nobody said it was, if the ONLY people selling were the shorters then it would be impossible for them to make money. They need people to panic sell for them to make money.
Stu, err no. Like I have stated my belief is hemo will announce a funding package along side the start of trials. It's literally on the prevail website, they invest and fund clinical trials!
I can have noodles AND rice with my dinner, the presence of the rice does not some how change the fact there is noodles on my plate.
Of course mint was damaging, they did alot of forward selling/shorting. When I found out who was connected I spent alot of time lobbying vlad to get rid and managed to recruit alot of people to take part in the placement to repay the CLNs.
Why would I not acknowledge that? If you forget our past your doomed to repeat.
The other even bigger mistake they made was much earlier than Mint was the investors they chose for the initial RTO.
Does not mean that suddenly shorters get a free pass to attack a company trying to save lives without criticism. It's wrong and you know it.
Stu has answered, nothing makes it special, the key in his answer was "Financial resources at hand" and THIS is where we agree. The risk to Hemogenyx, and its not really a risk but more of an impediment, is the lack of significant "Financial resources at hand" due in no small part to the low mCap which is due in no small part to the shorting and trading. If the company had a considerably higher mCap it would be much harder to short and attack, this would make it easier to raise funds when needed and would in turn lead to a higher and safer valuation. Which basically means your arguing FOR the very argument I am making! Which just re-enforces that your not that stupid, you just want to create just enough noise to put some people off to get your trade away. So basically your just trying to waste my time to fill this board with useless noise and detract from the fact that 2 weeks ago Hemogenyx got their Clinical Hold lifted by the FDA and are now CLINICAL and allowed to start Clinical trials with HEMO-CAR-T.
GO HEMO! :-)
If its all really simple Stu then perhaps you could educate us?
What makes Hemogenyx special?
Why is Hemogenyx the outlier? Why is EVERY other company with CAR-T in clinical trials significantly higher than us? What is so special about hemogenyx that the risk here is so much higher than EVERY other pharma company out there doing CAR-T? AND there are companies also targeting AML, they dont seem to have the same issues with valuation.
The difference?
Hemogenyx is higher risk BECAUSE ITS SO CHEAP. The lower mCap makes it harder and more damaging to raise funds via placings and makes it MUCH easier to manipulate by fewer people and less resources. You know the biggest risk to Hemogenyx is the low mCap, your not an idiot, you also know its that low mCap and low volumes and low visibility which make it so attractive to you and others who short and trade here. It is just not cool that you have picked a company that literally wants to save lives when there are much better targets out there that do nothing but fleece shareholders and their activities directly or indirectly cause cancer!
Err Truffle, there is PLENTY wrong with shorting, its acceptable for providing liquidity in a market where people want to buy and there is just no stock. Or in a company where they have been exposed to be a fraud or criminal enterprise of some sort. Or where some sort of pump and dump scheme being orchestrated by directors etc. There are cases where it is appropriate.
HOWEVER all we see these days is traders either knowing or just suspecting a placing in a small cap short sell as hard and as much as possible in an attempt to force the SP down, then following up with trolling posts. The intent to make the SP as low as possible incase there is a placing to maximise their profits. The issue? This DOES hurt the company, it makes it very hard to raise any sizeable amount of money, there is a limit to how many shares can be issued.
With Hemogenyx it has happened so much and so many times that Vlad has had to curtail research over the years, reduce the work to keep within what he could afford. At this point Hemogenyx could well have been in clinical trials for CAR-T and CBR by now if money had been no issue, lives COULD have been saved already.
Shorting 100% has a direct negative impact on the company and it is NOT a legitimate form of trading as all too often its associated with market manipulation, abuse and insider trading.
Hemogenyx was at 7p when the news landed on FDA approval, between shorting AND traders selling the SP is now back at 3p. At 7p the company would have had no issue whatsoever raising 10m or so to fund CBR research at 6p and nobody would have complained, now? they will probably have to wait a while to raise and settle for moving CAR-T along. Shorting Hemogenyx is out of control, disgusting and the delays will cost lives, if not done so already.
Yes, IG last report was 80-90mil shares on their site, I use IG alot and have added and know others who have also bought who use IG so honestly IMO they have more, but I am not paying 100 quid to get the updated register.... 11% of share positions by clients on IG ONLY, so we are talking somewhere in the 8-10mil range for IG. IB last BIG chunk was like 12mil borrowed back when the FDA lifted the hold, other smaller borrowings before and after but again, some closing and I cba to work out exact positions. Bottom line is I have 3 broker accounts and 2 of them allow shorting in Hemogenyx so its not exactly a stretch to assume many others do also. So that 20m figure being quoted as short is probably quite conservative, it is impossible to know the exact total.
IG....err.... perhaps you are in need of corrective glasses :P OF COURSE you can short Hemogenyx!
This is literally a copy and paste from the IG website: "11% have short positions"
on IB its a chart showing numbers borrowed so you have to do your own maths. There are others but I cba to register for them all.
Truffle, register as professional and you can do alot more.... Quite often though you have to ring up, spreadex will let you short but you must ring up. But at this point there is no real debate, IG, IB etc display the short interest on their sites, so its a guesstimate as to the total size of current shorts as IG for example only give percentages,( Currently 11%) but 20m seems conservative.
They can use whatever size they want? I just gave an example of 100k. And to be honest if its spread bet it wont print like that anyway, they try and close positions with IG or IB or II or whoever and that broker lets them close xyz amount and then they will do a consolidation and balancing trade if required to reduce their exposure which could be 500k in an after hours trade print. What I am saying is, yes its entirely possible to close in small steps, and if they have a really good broker they can possibly get out with decent profit before the SP moves much. 20m is alot though, but I assume there is more than one person shorting here, so first mover advantage and all that...
Individuals have shorted Hemogenyx, not a company, but yes, if they start buying small blocks, 100k or so they could start closing without moving the SP too much, but with that much stock short it would take a long time. But like I said to Stu before, if he manages it down here? He will have made profit and won, at the expense of a company looking to cure people with cancer, so good luck.....